Evaluation of the Immunologic Impact of RAF Inhibitors to Guide Optimal Combination of RAF Inhibitors and Immunotherapy for the Treatment of Advanced Melanoma

doi 10.21236/ada621079
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Effects of RAF Inhibitors on PI3K/AKT Signalling Depend on Mutational Status of the RAS/RAF Signalling Axis

Oncotarget
Oncology
2016English

A New B-Raf Inhibitor Combo for Advanced Melanoma

Oncotarget
Oncology
2018English

HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells

Oncotarget
Oncology
2017English

Next-Generation RAF Inhibitors Prevent Paradoxical MAPK Activation

Cancer Discovery
Oncology
2015English

The Combination of Novel Low Molecular Weight Inhibitors of RAF (LBT613) and Target of Rapamycin (RAD001) Decreases Glioma Proliferation and Invasion

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2020English

Tumour Micro-Environment Elicits Innate Resistance to RAF Inhibitors Through HGF Secretion

Nature
Multidisciplinary
2012English

Azologization of a Hetero-Stilbene Based C-Raf Kinase Inhibitor: Towards the Design of Photoswitchable Sirtuin Inhibitors

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy